CTXR - CIK 0001506251
Citius Pharmaceuticals, Inc. has filed 625 documents with the SEC between 2010 and 2026. The most frequent type is major company event (181 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Insider trade | 4 | 2021-10-13 | 2021-10-11 |
| Major company event | 8-K | 2021-09-07 | 2021-09-01 |
| Major company event | 8-K | 2021-08-12 | 2021-08-12 |
| Quarterly report | 10-Q | 2021-08-12 | 2021-06-30 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| Insider trade | 4 | 2021-07-26 | 2021-07-22 |
| 424B4 | - | 2021-07-23 | - |
| EFFECT | - | 2021-07-08 | - |
| Major company event | 8-K | 2021-07-07 | 2021-07-07 |
| POS AM | - | 2021-07-02 | - |
| Major company event | 8-K | 2021-07-01 | 2021-07-01 |
| Employee stock plan | S-8 | 2021-06-22 | - |
| Major company event (amended) | 8-K/A | 2021-06-22 | 2021-05-24 |
| Major company event | 8-K | 2021-06-08 | 2021-06-08 |
| Major company event | 8-K | 2021-06-07 | 2021-06-07 |
| Proxy materials | DEFA14A | 2021-05-28 | - |
| Major company event | 8-K | 2021-05-24 | 2021-05-24 |
| EFFECT | - | 2021-05-20 | - |
| 424B3 | - | 2021-05-20 | - |
| Company correspondence | CORRESP | 2021-05-19 | - |
| SEC correspondence | UPLOAD | 2021-05-18 | - |
| Securities registration | S-3 | 2021-05-13 | - |
| Quarterly report | 10-Q | 2021-05-13 | 2021-03-31 |
| Major company event | 8-K | 2021-05-13 | 2021-05-13 |
| EFFECT | - | 2021-04-16 | - |
| 424B3 | - | 2021-04-16 | - |
| Company correspondence | CORRESP | 2021-04-12 | - |
| Proxy materials | DEFA14A | 2021-04-12 | - |
| Proxy statement | DEF 14A | 2021-04-12 | 2021-05-24 |
| SEC correspondence | UPLOAD | 2021-04-09 | - |
| Securities registration | S-3 | 2021-04-02 | - |
| 424B3 | - | 2021-04-01 | - |
| 424B3 | - | 2021-03-26 | - |
| SEC STAFF LETTER | - | 2021-03-12 | - |
| PRE 14A | - | 2021-03-12 | 2021-03-12 |
| Major company event | 8-K | 2021-02-19 | 2021-02-16 |
| Insider trade | 4 | 2021-02-18 | 2021-02-16 |
| Insider trade | 4 | 2021-02-18 | 2021-02-16 |
| Insider trade | 4 | 2021-02-18 | 2021-02-16 |